For example, the reduced risk of retinopathy associated with intensive insulin therapy persisted for up to 10 years in the observational follow-up EDIC study, despite the convergence of HbA1c levels in the intensive and conventional groups (HbA1c∼8.0%; Figure 2) (9). This evidence concerns the gene INS and retinal disorder.